Kuros Biosciences AG/€KURN
06:30
10:10
13:45
17:25
21:00
1D1W1MYTD1Y5YMAX
About Kuros Biosciences AG
Kuros Biosciences AG is a biotechnology company based in Switzerland, focused on the development of products for tissue repair and regeneration. Core to its business are biomaterial-based products designed to support bone healing in specific medical conditions. Its product portfolio includes innovative solutions like MagnetOs, used for spinal fusion; it is designed to enhance the body’s natural bone healing process. The company, headquartered in Schlieren, Switzerland, leverages its proprietary technologies to target significant unmet medical needs, positioning itself in the niche market of orthobiologics. Kuros Biosciences emphasizes innovation in biologics and synthetic solutions, aiming for a competitive edge in the healthcare sector.
Ticker
€KURN
Sector
Primary listing
XGAT
Employees
158
Headquarters
Schlieren, Switzerland
Website
KURN Metrics
BasicAdvanced
€1.2B
-
-€0.14
0.61
-
Price and volume
Market cap
€1.2B
Beta
0.61
52-week high
€37.10
52-week low
€14.93
Average daily volume
7.8K
Financial strength
Current ratio
2.251
Quick ratio
1.679
Long term debt to equity
1.485
Total debt to equity
2.337
Interest coverage (TTM)
0.72%
Profitability
EBITDA (TTM)
6.251
Gross margin (TTM)
88.70%
Net profit margin (TTM)
-5.87%
Operating margin (TTM)
3.73%
Effective tax rate (TTM)
-22.34%
Revenue per employee (TTM)
€697,570
Management effectiveness
Return on assets (TTM)
2.57%
Return on equity (TTM)
-8.62%
Valuation
Price to revenue (TTM)
12.179
Price to book
14.56
Price to tangible book (TTM)
32.03
Price to free cash flow (TTM)
-1,873.199
Free cash flow yield (TTM)
-0.05%
Free cash flow per share (TTM)
-0.016
Growth
Revenue change (TTM)
83.30%
Earnings per share change (TTM)
-54.63%
3-year revenue growth (CAGR)
89.64%
3-year earnings per share growth (CAGR)
-26.18%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Kuros Biosciences AG stock?
Kuros Biosciences AG (KURN) has a market cap of €1.2B as of December 19, 2025.
What is the P/E ratio for Kuros Biosciences AG stock?
The price to earnings (P/E) ratio for Kuros Biosciences AG (KURN) stock is 0 as of December 19, 2025.
Does Kuros Biosciences AG stock pay dividends?
No, Kuros Biosciences AG (KURN) stock does not pay dividends to its shareholders as of December 19, 2025.
When is the next Kuros Biosciences AG dividend payment date?
Kuros Biosciences AG (KURN) stock does not pay dividends to its shareholders.
What is the beta indicator for Kuros Biosciences AG?
Kuros Biosciences AG (KURN) has a beta rating of 0.61. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.